A new class of small molecule therapeutics: Molecular Gates
Gate Bioscience creates a new class of small molecule therapeutics called Molecular Gates. Backed by a16z, Forbion, Versant. 2025 collaboration with Eli Lilly following $65M Series B.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2025
Nov 2025
Nov 2023
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...